Modelling and analysis of influenza A (H1N1) on networks

BMC Public Health. 2011 Feb 25;11 Suppl 1(Suppl 1):S9. doi: 10.1186/1471-2458-11-S1-S9.

Abstract

Background: In April 2009, a new strain of H1N1 influenza virus, referred to as pandemic influenza A (H1N1) was first detected in humans in the United States, followed by an outbreak in the state of Veracruz, Mexico. Soon afterwards, this new virus kept spreading worldwide resulting in a global outbreak. In China, the second Circular of the Ministry of Health pointed out that as of December 31, 2009, the country's 31 provinces had reported 120,000 confirmed cases of H1N1.

Methods: We formulate an epidemic model of influenza A based on networks. We calculate the basic reproduction number and study the effects of various immunization schemes. The final size relation is derived for the network epidemic model. The model parameters are estimated via least-squares fitting of the model solution to the observed data in China.

Results: For the network model, we prove that the disease-free equilibrium is globally asymptotically stable when the basic reproduction is less than one. The final size will depend on the vaccination starting time, T, the number of infective cases at time T and immunization schemes to follow. Our theoretical results are confirmed by numerical simulations. Using the parameter estimates based on the observation data of the cumulative number of hospital notifications, we estimate the basic reproduction number R0 to be 1.6809 in China.

Conclusions: Network modelling supplies a useful tool for studying the transmission of H1N1 in China, capturing the main features of the spread of H1N1. While a uniform, mass-immunization strategy helps control the prevalence, a targeted immunization strategy focusing on specific groups with given connectivity may better control the endemic.

MeSH terms

  • Basic Reproduction Number
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza Vaccines* / administration & dosage
  • Influenza, Human / epidemiology*
  • Influenza, Human / transmission*
  • Models, Biological
  • Pandemics / statistics & numerical data*

Substances

  • Influenza Vaccines